|
OA
|
AVN
|
Other
|
---|
|
ORa(95% CI)
|
P-value
|
ORa(95% CI)
|
P-value
|
ORa(95% CI)
|
P-value
|
---|
Moderate-severe overall ADL limitationb
| | | | | | |
Two-years
|
0.5 (0.3,0.8)
|
0.01
|
0.4 (0.2 to 0.8)
|
0.01
|
1.0 (0.5 to 1.9)
|
0.91
|
Five-years
|
0.7 (0.4 to 1.4)
|
0.36
|
0.9 (0.4 to 1.8)
|
0.78
|
2.1 (0.9 to 4.8)
|
0.07
|
Moderate-severe hip painc
| | | | | | |
Two-years
|
1.6 (0.6 to 4.5)
|
0.40
|
2.8 (0.9 to 8.5)
|
0.06
|
2.2 (0.6 to 7.3)
|
0.22
|
Five-years
|
2.1 (0.7 to 6.5)
|
0.22
|
4.1 (1.2 to 14.1)
|
0.02
|
4.2 (1.1 to 16.0)
|
0.04
|
-
aReference category is rheumatoid arthritis/inflammatory arthritis; badjusted for 16 additional covariates/confounders: age, gender, BMI, Deyo-Charlson comorbidity score, ASA class, distance from the medical center, cement fixation, preoperative limitation in seven activities, anxiety and depression; cadjusted for 10 additional covariates/confounders: age, gender, BMI, Deyo-Charlson comorbidity score, ASA class, distance from the medical center, cement fixation, preoperative pain, anxiety and depression. Numbers in bold represents significant p-value <0.05. ADL, activities of daily living; ASA, American Society of Anesthesiologists; AVN, avascular necrosis of bone; BMI, body mass index; CI, confidence interval; OA, osteoarthritis; OR, odds ratio; RA, rheumatoid arthritis; THA, total hip arthroplasty.